Adaptation of an enrichment-free Listeria diagnostic to food matrices
将无富集李斯特菌诊断方法应用于食品基质
基本信息
- 批准号:9346485
- 负责人:
- 金额:$ 51.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2017-12-31
- 项目状态:已结题
- 来源:
- 关键词:AmericanAreaBackBacterial InfectionsBacteriophagesBiological AssayBusinessesCampylobacterCantaloupesCase StudyCategoriesCause of DeathCellsCenters for Disease Control and Prevention (U.S.)Cessation of lifeClinicalCollectionConsumptionDataDetectionDevelopmentDiabetes MellitusDiagnosticDiseaseDisease OutbreaksEatingEngineeringEnvironmentEnzymesEscherichia coliEtiologyFoodFood ContaminationFood SafetyGuidelinesHealthHealth Care CostsHealthcareHospitalizationHumanIce CreamIncidenceIndividualIndustrializationIndustryInfectionIrritable Bowel SyndromeKidney FailureLaboratoriesLeftLifeListeriaListeria monocytogenesLocationManufacturer NameMeasuresMeatMedicalMethodsModalityPancreatitisPathogen detectionPersonsPhasePlantsPopulationProcessProductionPublic HealthReagentReportingResearch PersonnelRiskSafetySalmonellaSamplingShippingSignal TransductionSourceSpecificitySurfaceSystemTechnologyTest ResultTestingTimeUnited States Food and Drug AdministrationValidationWaterWorkassay developmentbaseclinically relevantcostdiabeticdisorder preventionfood qualityfoodbornefoodborne illnessfoodborne pathogengastrointestinalmicrobialmortalitynew technologynoveloffenderpathogenphase 2 studysafety testingscreeningshift worksurveillance network
项目摘要
Abstract
Foodborne illnesses devastate the gastrointestinal microflora of millions of Americans each year, often resulting
in dysbiosis and increase risk of other diseases, namely irritable bowel syndrome, kidney failure, pancreatitis
and diabetes. Furthermore, diabetics are at increased risk of developing a foodborne illness, and they often take
longer to recover. Each year, 1 in 6 people in the U.S. are sickened by foodborne pathogens. In 2014, there
were 19,542 laboratory confirmed infections, 4,445 hospitalizations and 71 deaths attributed to the 9 major
pathogens transmitted commonly through food. Listeria is the one of the most serious offenders, with a 96%
hospitalization rate and a 12.9% mortality rate. The impact on healthcare, business and industry is no less
pronounced, resulting in annual costs of $14.1 to $16.3 billion, including direct medical costs and value of time
lost to illness. Moreover, the cost of keeping food safe from Listeria contamination was estimated to range
between $2.4-$2.6 billion. Contaminated food is the cause of these illnesses, having entered the public supply
due to a lack of detection at a manufacturing/packaging plant, distribution warehouse or retail location. Current
tests are inadequate because they require a prolonged enrichment step to reduce the likelihood of false
negatives and false positives. This enrichment causes tremendous delays in providing actionable results to the
food processor, who are left with one of two choices: Store the products until the test result comes back, resulting
in older, lower-quality food; or shipping the food before receiving test results, putting the consuming public at
increased risk. Sample6 is developing the world’s first enrichment-free foodborne pathogen detection system.
DETECT/L is a rapid screening assay that detects a single Listeria spp. cell on environmental surfaces in less
than one work shift (<7h). Sample6’s proprietary Bioillumination Platform enables this expeditious turnaround,
enabling food manufacturers and packagers to quickly and accurately detect and remediate contaminated
environmental surfaces, and solely retain product that is at risk of contamination. However, food can become
contaminated internally during production, shipping, or in wholesale and retail environments downstream in the
supply chain. It is of vital importance to develop a second testing modality that assays the foodstuff as rapidly
and sensitively as DETECT/L does for environmental surfaces. To this end, the proposed Phase II study will
continue the work begun in Phase I to adapt the DETECT/L assay for finished product testing. First, the
researchers will expand the number of Listeria strains to 10. Next, assay development will be completed for the
six foods begun in Phase I, plus 30 more foods. Finally, Sample6 will develop high-throughput methods so that
food manufacturers and packagers can test multiple food samples at a time for efficiency.
抽象的
食源性疾病每年都会破坏数百万美国人的胃肠道微生物群,通常导致
生态失调并增加其他疾病的风险,即肠易激综合征、肾衰竭、胰腺炎
此外,糖尿病患者患食源性疾病的风险增加,并且他们经常服用药物。
2014 年,美国有六分之一的人感染食源性病原体。
共有 19,542 例实验室确诊感染、4,445 例住院治疗和 71 例死亡归因于 9 个主要疾病
通常通过食物传播的病原体是最严重的致病菌之一,占 96%。
住院率和 12.9% 的死亡率对医疗保健、商业和工业的影响也不小。
明显,导致每年 14.1 至 163 亿美元的费用,包括直接医疗费用和时间价值
此外,据估计,保持食品安全免受李斯特菌污染的成本也很高。
2.4-26 亿美元之间的受污染食品是这些疾病的原因,已进入公共供应。
由于制造/包装工厂、分销仓库或零售地点缺乏检测。
测试是不充分的,因为它们需要长时间的富集步骤以减少错误的可能性
这种丰富性导致向提供可操作结果的过程中出现巨大的延迟。
食品加工商,他们有两个选择之一:储存产品直到测试结果返回,结果
在收到测试结果之前运送食品,使消费者处于危险之中
Sample6 正在开发世界上第一个无浓缩食源性病原体检测系统。
DETECT/L 是一种快速筛查方法,可在更短的时间内检测环境表面上的单个李斯特菌细胞。
Sample6 的专有生物照明平台只需一个工作班次(<7 小时)即可实现这一快速周转,
使食品制造商和包装商能够快速准确地检测和修复受污染的物质
环境表面,并仅保留有污染风险的产品。但是,食品可能会受到污染。
在生产、运输或下游批发和零售环境中内部受到污染
开发第二种快速检测食品的检测方式至关重要。
并像 DETECT/L 对环境表面所做的那样敏感。为此,拟议的第二阶段研究将进行。
继续第一阶段开始的工作,使 DETECT/L 适合成品测试。
研究人员将把李斯特菌菌株的数量扩大到 10 个。下一步,该检测方法的开发将完成
第一阶段开始的六种食物,加上另外 30 种食物,最后,Sample6 将开发高通量方法,以便
食品制造商和包装商可以一次测试多个食品样品以提高效率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Sandor Koeris其他文献
Michael Sandor Koeris的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Sandor Koeris', 18)}}的其他基金
Combining Bacteriophage-Mediated Decolonization with Microbial Engraftment to Foster Sustained Supragingival Microbiome Modulation for Enhanced Anti-Cariogenic Therapy
将噬菌体介导的去定植与微生物植入相结合,促进龈上微生物组的持续调节,以增强抗龋齿治疗
- 批准号:
10307172 - 财政年份:2021
- 资助金额:
$ 51.69万 - 项目类别:
Combining Bacteriophage-Mediated Decolonization with Microbial Engraftment to Foster Sustained Supragingival Microbiome Modulation for Enhanced Anti-Cariogenic Therapy
将噬菌体介导的去定植与微生物植入相结合,促进龈上微生物组的持续调节,以增强抗龋齿治疗
- 批准号:
10080641 - 财政年份:2020
- 资助金额:
$ 51.69万 - 项目类别:
Phage-Based Blood Test to Detect Bacterial Infections at the Point of Care
基于噬菌体的血液检测可在护理点检测细菌感染
- 批准号:
9568943 - 财政年份:2017
- 资助金额:
$ 51.69万 - 项目类别:
Enrichment-free Salmonella detection for food safety
用于食品安全的无富集沙门氏菌检测
- 批准号:
9409755 - 财政年份:2017
- 资助金额:
$ 51.69万 - 项目类别:
Adaptation of enrichment-free Listeria diagnostic to food matrices
免富集李斯特菌诊断对食品基质的适应
- 批准号:
9046705 - 财政年份:2015
- 资助金额:
$ 51.69万 - 项目类别:
相似国自然基金
开发区跨界合作网络的形成机理与区域效应:以三大城市群为例
- 批准号:42301183
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
秦岭生态效益转化与区域绿色发展模式
- 批准号:72349001
- 批准年份:2023
- 资助金额:200 万元
- 项目类别:专项基金项目
我国西南地区节点城市在次区域跨国城市网络中的地位、功能和能级提升研究
- 批准号:72364037
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
通过自主研发的AAV8-TBG-LOX-1基因治疗技术祛除支架区域氧化型低密度脂蛋白抑制支架内新生动脉粥样硬化研究
- 批准号:82370348
- 批准年份:2023
- 资助金额:47 万元
- 项目类别:面上项目
政府数据开放与资本跨区域流动:影响机理与经济后果
- 批准号:72302091
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Operant conditioning of sensory evoked potentials to reduce phantom limb pain
感觉诱发电位的操作性条件反射可减少幻肢痛
- 批准号:
10703170 - 财政年份:2023
- 资助金额:
$ 51.69万 - 项目类别:
Genomics and sero-epidemiology of Plasmodium falciparum malaria in a pre-elimination setting
消灭前环境中恶性疟原虫疟疾的基因组学和血清流行病学
- 批准号:
10666280 - 财政年份:2023
- 资助金额:
$ 51.69万 - 项目类别:
Identifying the Effects of Race-Related Stressors on Laboratory- Induced Stress and Craving among African Americans with Alcohol Use Disorder
确定种族相关压力源对患有酒精使用障碍的非裔美国人实验室诱发的压力和渴望的影响
- 批准号:
10664454 - 财政年份:2023
- 资助金额:
$ 51.69万 - 项目类别:
40th National Neurotrauma Society (NNS) Annual Symposium 2023 - Celebrating the Landmarks of Neurotrauma
2023 年第 40 届国家神经创伤协会 (NNS) 年度研讨会 - 庆祝神经创伤的里程碑
- 批准号:
10753817 - 财政年份:2023
- 资助金额:
$ 51.69万 - 项目类别:
Validation of biomarkers of infant and toddler carotenoid intake
婴幼儿类胡萝卜素摄入量生物标志物的验证
- 批准号:
10636537 - 财政年份:2023
- 资助金额:
$ 51.69万 - 项目类别: